Expression of vascular endothelial growth factor in experimental choroidal neovascularization

被引:224
作者
Ishibashi, T [1 ]
Hata, Y [1 ]
Yoshikawa, H [1 ]
Nakagawa, K [1 ]
Sueishi, K [1 ]
Inomata, H [1 ]
机构
[1] KYUSHU UNIV 60,FAC MED,DEPT PATHOL,HIGASHI KU,FUKUOKA 812,JAPAN
关键词
D O I
10.1007/BF00941723
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Although the choroidal neovascularization (CNV) is a common pathologic feature of a number of different eye diseases, its pathological mechanisms have not been fully elucidated. We investigated the expression of vascular endothelial growth factor (VEGF) in CNV using an experimental primate model. a Method: CNV was induced by intense laser photocoagulation in four monkey eyes. Single eyes were enucleated at 1, 3, 7 or 14 days after photocoagulation and examined immunohistochemically for VEGF, macrophage antigen, von Willebrand factor and glial fibrillary acidic protein (GFAP). Expression of VEGF mRNA was examined by in situ hybridization. Results: One day after photocoagulation, the normal structure of the outer portion of the retina and the inner portion of the choroid was destroyed. Three days after photocoagulation, choroidal vascular endothelial cells migrated into the subretinal space through the defect in Bruch's membrane. Increased expression of VEGF was detected in the accumulating macrophages, migrating retinal pigment epithelial (RPE) cells and Muller cells. Maximal expression of VEGF was observed between 3 and 7 days after wounding, and many newly formed vessels extended into the subretinal space 7-14 days after photocoagulation. a Conclusion: VEGF derived from RPE cells, macrophages and Muller cells may play a role in the formation of CNV.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 43 条
  • [1] SYNTHESIS AND SECRETION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR BY HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS
    ADAMIS, AP
    SHIMA, DT
    YEO, KT
    YEO, TK
    BROWN, LF
    BERSE, B
    DAMORE, PA
    FOLKMAN, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (02) : 631 - 638
  • [2] AIELLO LP, 1994, INVEST OPHTH VIS SCI, V5, P1868
  • [3] AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178
  • [4] ELECTRON-MICROSCOPIC FEATURES OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION
    ARCHER, DB
    GARDINER, TA
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (04) : 433 - 457
  • [5] BIGNAMI A, 1979, EXP EYE RES, V28, P63
  • [6] EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING
    BROWN, LF
    YEO, KT
    BERSE, B
    YEO, TK
    SENGER, DR
    DVORAK, HF
    VANDEWATER, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1375 - 1379
  • [7] VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION
    CLAUSS, M
    GERLACH, M
    GERLACH, H
    BRETT, J
    WANG, F
    FAMILLETTI, PC
    PAN, YCE
    OLANDER, JV
    CONNOLLY, DT
    STERN, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) : 1535 - 1545
  • [8] PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS
    FERRARA, N
    HENZEL, WJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 851 - 858
  • [9] FINKENZELLER G, 1992, CANCER RES, V52, P4821
  • [10] GASS JDM, 1967, AM J OPHTHALMOL, V573, P1